| GO ID | GO:0046854 |
| Ontology | BP |
| GO Term | phosphatidylinositol phosphorylation |
| Definition | The process of introducing one or more phosphate groups into a phosphatidylinositol, any glycerophosphoinositol having one phosphatidyl group esterified to one of the hydroxy groups of inositol. |
| Gene Symbol | Description | Entrez ID | Uniprot ID | Chromosomal Location |
|---|---|---|---|---|
|
PIK3CD |
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta |
5293 |
O00329 |
chr1: 9,651,732-9,729,114 |
|
PIK3C2A |
phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 alpha |
5286 |
O00443 |
chr11: 17,077,730-17,207,983 |
|
EREG |
epiregulin |
2069 |
O14944 |
chr4: 74,365,143-74,388,751 |
|
PIP5K1B |
phosphatidylinositol-4-phosphate 5-kinase, type I, beta |
8395 |
O14986 |
chr9: 68,705,414-69,009,176 |
|
PIP5K1C |
phosphatidylinositol-4-phosphate 5-kinase, type I, gamma |
23396 |
O60331 |
chr19: 3,630,183-3,700,479 |
|
FGF18 |
fibroblast growth factor 18 |
8817 |
O76093 |
chr5: 171,419,656-171,457,623 |
|
FGF19 |
fibroblast growth factor 19 |
9965 |
O95750 |
chr11: 69,698,232-69,704,642 |
|
EGFR |
epidermal growth factor receptor |
1956 |
P00533 |
chr7: 55,019,021-55,211,628 |
|
PDGFB |
platelet-derived growth factor beta polypeptide |
5155 |
P01127 |
chr22: 39,223,359-39,244,751 |
|
PDGFA |
platelet-derived growth factor alpha polypeptide |
5154 |
P04085 |
chr7: 497,258-520,296 |
|
ERBB2 |
erb-b2 receptor tyrosine kinase 2 |
2064 |
P04626 |
chr17: 39,687,914-39,730,426 |
|
FYN |
FYN proto-oncogene, Src family tyrosine kinase |
2534 |
P06241 |
chr6: 111,660,332-111,873,452 |
|
FGF2 |
fibroblast growth factor 2 (basic) |
2247 |
P09038 |
chr4: 122,826,708-122,898,236 |
|
PDGFRB |
platelet-derived growth factor receptor, beta polypeptide |
5159 |
P09619 |
chr5: 150,113,837-150,155,872 |
|
KIT |
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog |
3815 |
P10721 |
chr4: 54,657,918-54,740,715 |
|
CD28 |
CD28 molecule |
940 |
P10747 |
chr2: 203,706,475-203,738,912 |
|
FGFR1 |
fibroblast growth factor receptor 1 |
2260 |
P11362 |
chr8: 38,411,138-38,468,834 |
|
VAV1 |
vav guanine nucleotide exchange factor 1 |
7409 |
P15498 |
chr19: 6,772,714-6,857,366 |
|
PDGFRA |
platelet-derived growth factor receptor, alpha polypeptide |
5156 |
P16234 |
chr4: 54,229,097-54,298,247 |
|
KITLG |
KIT ligand |
4254 |
P21583 |
chr12: 88,492,793-88,580,851 |
|
FGF7 |
fibroblast growth factor 7 |
2252 |
P21781 |
chr15: 49,423,096-49,488,775 |
|
FGFR2 |
fibroblast growth factor receptor 2 |
2263 |
P21802 |
chr10: 121,478,334-121,598,458 |
|
ERBB3 |
erb-b2 receptor tyrosine kinase 3 |
2065 |
P21860 |
chr12: 56,079,857-56,103,505 |
|
PIK3R1 |
phosphoinositide-3-kinase regulatory subunit 1 |
5295 |
P27986 |
chr5: 68,215,720-68,301,821 |
|
IMPA1 |
inositol(myo)-1(or 4)-monophosphatase 1 |
3612 |
P29218 |
chr8: 81,657,961-81,686,693 |
|
FGF9 |
fibroblast growth factor 9 |
2254 |
P31371 |
chr13: 21,671,383-21,704,498 |
|
BTC |
betacellulin |
685 |
P35070 |
chr4: 74,744,759-74,794,686 |
|
IRS1 |
insulin receptor substrate 1 |
3667 |
P35568 |
chr2: 226,731,317-226,799,759 |
|
PIK3CA |
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha |
5290 |
P42336 |
chr3: 179,148,114-179,240,093 |
|
PIK3CB |
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta |
5291 |
P42338 |
chr3: 138,652,699-138,834,938 |
|
PIK3CG |
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma |
5294 |
P48736 |
chr7: 106,865,278-106,907,145 |
|
INPP1 |
inositol polyphosphate-1-phosphatase |
3628 |
P49441 |
chr2: 190,343,470-190,371,665 |
|
GRB2 |
growth factor receptor bound protein 2 |
2885 |
P62993 |
chr17: 75,318,076-75,405,709 |
|
PIP4K2B |
phosphatidylinositol-5-phosphate 4-kinase, type II, beta |
8396 |
P78356 |
chr17: 38,765,689-38,800,126 |
|
NRG1 |
neuregulin 1 |
3084 |
Q02297 |
chr8: 31,639,386-32,767,959 |
|
PTPN11 |
protein tyrosine phosphatase, non-receptor type 11 |
5781 |
Q06124 |
chr12: 112,418,351-112,509,913 |
|
GAB1 |
GRB2 associated binding protein 1 |
2549 |
Q13480 |
chr4: 143,336,762-143,474,568 |
|
ERBB4 |
erb-b2 receptor tyrosine kinase 4 |
2066 |
Q15303 |
chr2: 211,375,717-212,538,841 |
|
TMEM150A |
transmembrane protein 150A |
129303 |
Q86TG1 |
chr2: 85,598,548-85,603,196 |
|
TTC7B |
tetratricopeptide repeat domain 7B |
145567 |
Q86TV6 |
chr14: 90,524,564-90,816,479 |
|
PIK3C3 |
phosphatidylinositol 3-kinase catalytic subunit type 3 |
5289 |
Q8NEB9 |
chr18: 41,955,206-42,087,830 |
|
FRS2 |
fibroblast growth factor receptor substrate 2 |
10818 |
Q8WU20 |
chr12: 69,470,349-69,579,789 |
|
SMG1 |
SMG1 phosphatidylinositol 3-kinase-related kinase |
23049 |
Q96Q15 |
chr16: 18,804,853-18,926,454 |
|
HBEGF |
heparin-binding EGF-like growth factor |
1839 |
Q99075 |
chr5: 140,332,843-140,346,631 |
|
PI4KB |
phosphatidylinositol 4-kinase, catalytic, beta |
5298 |
Q9UBF8 |
chr1: 151,291,797-151,327,715 |
|
KL |
klotho |
9365 |
Q9UEF7 |
chr13: 33,016,433-33,066,145 |
|
IP6K2 |
inositol hexakisphosphate kinase 2 |
51447 |
Q9UHH9 |
chr3: 48,688,003-48,740,353 |
|
PIKFYVE |
phosphoinositide kinase, FYVE finger containing |
200576 |
Q9Y2I7 |
chr2: 208,266,267-208,358,751 |
|
IRS2 |
insulin receptor substrate 2 |
8660 |
Q9Y4H2 |
chr13: 109,752,698-109,786,568 |